Cambridge Investment Research Advisors
IBTX

Cambridge Investment Research Advisors’s Independent Bank Group, Inc. IBTX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IBTX Stock Details IBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,195
Closed -$376K – 3679
2024
Q4 		$376K Hold
6,195
– – ﹤0.01% 2657
2024
Q3 		$357K Sell
6,195
-11,750
-65% -$642K ﹤0.01% 2696
2024
Q2 		$817K Sell
17,945
-2,453
-12% -$105K ﹤0.01% 1917
2024
Q1 		$931K Buy
20,398
+139
+0.7% +$6.48K ﹤0.01% 1783
2023
Q4 		$1.03M Sell
20,259
-200
-1% -$8.12K ﹤0.01% 1640
2023
Q3 		$809K Buy
20,459
+295
+1% +$12K ﹤0.01% 1712
2023
Q2 		$696K Buy
20,164
+4,311
+27% +$160K ﹤0.01% 1885
2023
Q1 		$735K Hold
15,853
– – ﹤0.01% 1789
2022
Q4 		$952K Buy
+15,853
New +$1.01M ﹤0.01% 1541

Other funds holding IBTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cambridge Investment Research Advisors's IBTX Position: Q1 2025 in Review

Cambridge Investment Research Advisors sold out of Independent Bank Group, Inc. (IBTX) in Q1 2025, closing a stake of 6,195 shares — an estimated $376K sold.

Cambridge Investment Research Advisors first reported a position in IBTX in Q4 2022 and held it in 9 quarters. The position peaked at $1.03M in Q4 2023. 0 funds tracked by Wall St. Rank hold IBTX as of Q1 2025.

  • Cambridge Investment Research Advisors reported no remaining Independent Bank Group, Inc. position as of Q1 2025 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 6,195 Independent Bank Group, Inc. shares in Q1 2025, an estimated $376K.
  • Cambridge Investment Research Advisors first reported a position in Independent Bank Group, Inc. in Q4 2022 and held it in 9 quarters.
  • Cambridge Investment Research Advisors's Independent Bank Group, Inc. position peaked at $1.03M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Independent Bank Group, Inc. as of Q1 2025.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2025, filed 22 Apr 2025.